Development of a novel high-throughput analytical methodology, multiple injection method, for quantitative analysis in drug metabolism and pharmacokinetic studies using liquid chromatography with tandem mass spectrometry

Biological and Pharmaceutical Bulletin

Volumn 34, Issue 8, 2011, Pages 1187-1193

  Tanaka, Yukari ^a,b   Ohkawa, Tomoyuki ^a   Yasui, Hiroyuki ^b  

^a SHIONOGI AND CO LTD   (Japan)

^b KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

High throughput quantitative analysis; LC MS MS; Multiple injection method; Pharmacokinetic study

Indexed keywords

FEXOFENADINE; IMIPRAMINE; ONDANSETRON; RISPERIDONE; VERAPAMIL;

ANALYTIC METHOD; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG DETERMINATION; DRUG EFFICACY; DRUG METABOLISM; DRUG STRUCTURE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIGH THROUGHPUT SCREENING; INTERMETHOD COMPARISON; IONIZATION; MALE; MULTIPLE INJECTION METHOD; NONHUMAN; QUANTITATIVE ANALYSIS; RAT; SENSITIVITY ANALYSIS; TANDEM MASS SPECTROMETRY;

ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; IMIPRAMINE; MALE; ONDANSETRON; PHARMACEUTICAL PREPARATIONS; PHARMACOKINETICS; RATS; RATS, SPRAGUE-DAWLEY; RISPERIDONE; TANDEM MASS SPECTROMETRY; TERFENADINE; VALIDATION STUDIES AS TOPIC; VERAPAMIL;

EID: 80051506460     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.34.1187     Document Type: Article

References (36)

1. Xue Y. J., Akinsanya J. B., Liu J., Unger S. E., Rapid Commun. Mass Spectrom., 20, 2660-2668 (2006).
2. Briem S., Martinsson S., Bueters T., Skoglund E., Rapid Commun. Mass Spectrom., 21, 1965-1972 (2007).
3. Bu W., Nguyen M., Xu C., Lin C.-C., Yeh L. T., Borges V., J. Chromatogr. B, 852, 465-472 (2007).
4. Wang P. G., Wei S. J., Kim G., Chang M., El-Shourbagy T., J. Chromatogr. A, 1130, 302-307 (2006).
5. Bishop M. J., Crow B., Norton D., Paliakov E., George J., Bralley J. A., J. Chromatogr. B, 859, 164-169 (2007).
6. Zhou S., Zhou H., Larson M., Miller D. L., Mao D., Jiang X., Naidong W., Rapid Commun. Mass Spectrom., 19, 2144-2150 (2005).
7. Alnouti Y., Srinivasan K., Waddell D., Bi H., Kavetskaia O., Gusev A. I., J. Chromatogr. A, 1080, 99-106 (2005).
8. Huang M. Q., Mao Y., Jemal M., Arnold M., Rapid Commun. Mass Spectrom., 20, 1709-1714 (2006).
9. Zang X., Luo R., Song N., Chen T. K., Bozigian H., Rapid Commun. Mass Spectrom., 19, 3259-3268 (2005).
10. Xu N. R., Fan L., Kim E. G., El-Shourbagy A. T., J. Pharm. Biomed. Anal., 40, 728-736 (2006).
11. Vintiloiu A., Mullett W. M., Papp R., Lubda D., Kwong E., J. Chromatogr. A, 1082, 150-157 (2005).
12. Chassaing C., Stafford H., Luckwell J., Wright A., Edginton A., Chromatographia, 62, 17-24 (2005).
13. Hsieh S., Tobien T., Koch K., Dunn J., Rapid Commun. Mass Spectrom., 18, 285-292 (2004).
14. Lindqvist A., Hilke S., Skoglund E., J. Chromatogr. A, 1058, 121-126 (2004).
15. Roddy T. P., Horvath C. R., Stout S. J., Kenney K. L., Ho P. I., Zhang J. H., Vickers C., Kaushik V., Hubbard B., Wang Y. K., Anal. Chem., 79, 8207-8213 (2007).
16. Fung E. N., Chu I., Li C., Liu T., Soares A., Morrison R., Nomeir A. A., Rapid Commun. Mass Spectrom., 17, 2147-2152 (2003).
17. Smalley J., Kadiyala P., Xin B., Balimane P., Olah T., J. Chromatogr. B, 830, 270-277 (2006).
18. Deng Y., Wu J. T., Lloyd T. L., Chi C. L., Olah T. V., Unger S. E., Rapid Commun. Mass Spectrom., 16, 1116-1123 (2002).
19. Watanabe S., Suemaru K., Inoue N., Imai K., Aimoto T., Araki H., Naunyn Schmiedebergs Arch. Pharmacol., 378, 85-91 (2008).
20. Song W., Pabbisetty D., Groeber E. A., Steenwyk R. C., Fast D. M., J. Pharm. Biomed. Anal., 50, 491-500 (2009).
21. Qiang F., Lee J.-B., Lee W., Han K.-H., J. Pharm. Sci., 37, 413-417 (2009).
22. Yang H. S., Lee G. M., Biopharm. Drug Dispos., 29, 414-426 (2008).
23. Choi J. S., Burm J. P., Arch. Pharm. Res., 31, 1200-1204 (2008).
24. Piao Y. J., Choi J. S., Arch. Pharm. Res., 31, 518-522 (2008).
25. Zhang G., Terry A. V. Jr., Bartlett M. G., J. Chromatogr. B, 856, 20-28 (2007).
26. Zhang G., Terry A. V. Jr., Bartlett M. G., J. Chromatogr. B, 858, 276-281 (2007).
27. U.S. Department of Health and Human Services Food and Drug Administration, ⟨http://www.fda.gov/⟩, Guidance for Industry Bioanalytical Method Validation, May 2001, cited November 24, 2010.
28. Hill H. M., Chomatographia, 52, 565-569 (2000).
29. Shah V. P., Midha K. K., Dighe S., McGilveray I. J., Skelly J. P., Yacabi A., Layloff T., Viswanathan C. T., Cook C. E., McDowall R. D., Pittman K. A., Spector S., J. Pharm. Sci., 81, 309-312 (1992).
30. Yamaguchi J., Watanabe Y., Ohmichi M., Jingu S., Ogawa N., Kokatsu J., Fukushima K., Goto J., J. Chromatogr. B, 730, 61-70 (1999).
31. Zell M., Husser C., Hopfgartner G., J. Mass Spectrom., 32, 23-32 (1997).
32. Schmeer K., Sauter T., Schmid J., J. Chromatogr. A, 777, 67-72 (1997).
33. White R. E., Manitpisitkul P., Drug Metab. Dispos., 29, 957-966 (2001).
34. Yu K., Little D., Plumb R., Smith B., Rapid Commun. Mass Spectrom., 20, 544-552 (2006).
35. Mensch J., Noppe M., Adriaensen J., Melis A., Mackie C., Augustijns P., Brewster M. E., J. Chromatogr. B, 847, 182-187 (2007).
36. Bjørk M. K., Nielsen M. K. K., Markussen L. O., Klinke H. B., Linnet K., Anal. Bioanal. Chem., 396, 2393-2401 (2010).